September 13, 2018 Join Keystone Heart at TCT2018
We invite you to explore and discuss with world-renown physicians the importance of complete cerebral embolic protection with TAVR. Please join us for the Keystone Heart Lunch Symposium during TCT 2018where we will share current research on cerebral embolic debris during TAVR, progress of the US REFLECT trial using TriGUARD 3™, early US experience and commentary with TriGUARD 3™.
The Case for Complete Cerebral Embolic Protection-REFLECT
Saturday, September 22, 2018| Program: 1:00 pm-2:00 pm
Presentation Theater 4 (Exhibit Hall)| San Diego Convention Center
1:00 pm | Current Cerebral Embolic Protection Landscape – Keystone Heart TriGUARD Data Review
1:10 pm | REFLECT Clinical Trial Update with TriGUARD 3
1:20 pm | TriGUARD 3 Case Presentation- Early US Experience
1:28 pm | TriGUARD 3 Post-Market EU Registry Plan
1:35 pm | The Importance of DW-MRI and Longitudinal Impact of Cerebral Ischemic Lesions
1:45 pm | Cerebral Embolic Protection Panel Discussion
2:00 pm | Adjourn
TriGUARD 3™ is an investigational device and not commercially available in the United States.